The role of SDF-1/CXCR4 axis in ovarian cancer metastasis

Abstract

This study was aimed to explore the role of stromal-derived factor 1 (SDF-1)/CXC chemokine receptor 4 (CXCR4) axis in mediating the metastasis of ovarian cancer cells through activation of extracellular signal-regulated kinase-1/2 (ERK-1/2) signaling pathway. A highly metastatic ovarian cancer cell line, SKOV3, was used in the study. Intracellular calcium mobilization was detected by using laser scanning confocal fluorescence microscopy. Western blotting was used to detect the phosphorylation of ERK1/2 in SDF-1α-treated SKOV3 cells. Adhesion capability and matrix metalloproteinase (MMP) activity of ovarian cancer cells after exposure to SDF-1α were measured by adhesion assay and gelatin zymography. The results showed that SDF-1α induced rapid intracellular calcium mobilization in SKOV3 cells, as well as the phosphorylation of ERK-1/2. The adhesion of ovarian cancer cells to fibronectin and collagen IV was increased after SDF-1α treatment. An inhibitor of ERK-1/2 signaling, PD98059, could antagonize such effects of SDF-1α. SDF-1α could also increase the secretion of active MMP-2 and MMP-9. It was concluded that the SDF-1/CXCR4 axis played a critical role in the metastasis of human ovarian cancer by increasing the adhesion capability of cancer cells and the activity of MMP-2 and MMP-9 via ERK1/2 signaling pathway.

Keywords

ovarian cancer / metastasis / CXC chemokine receptor 4 / stromal-derived factor 1 / extracellular signal-regulated kinase-1/2

References

[1] BalkwillF.. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol, 2004, 14(3): 171-179

[2] GrunewaldM., AvrahamI., DorY., et al. . VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell, 2006, 124(1): 175-189

[3] KatayamaY., BattistaM., KaoW.M., et al. . Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell, 2006, 124(2): 407-421

[4] ZouY.R., KottmannA.H., KurodaM., et al. . Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature, 1998, 393(6685): 595-599

[5] BegleyL.A., MacDonaldJ.W., DayM.L., et al. . CXCL12 activates a robust transcriptional response in human prostate epithelial cells. J Biol Chem, 2007, 282(37): 26767-2674

[6] KuciaM., JankowskiK., RecaR., et al. . CXCR4-SDF-1 signaling, locomotion, chemotaxis and adhesion. J Mol Histol, 2004, 35(3): 233-245

[7] MullerA., HomeyB., SotoH., et al. . Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410(6824): 50-56

[8] OrimoA., GuptaP.B., SgroiD.C., et al. . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 2005, 121(3): 335-348

[9] MarchesiF., MontiP., LeoneB.E., et al. . Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res, 2004, 64(22): 8420-8427

[10] ScottonC.J., WilsonJ.L., MillikenD., et al. . Epithelial cancer cell migration: a role for chemokine receptors?. Cancer Res, 2001, 61(13): 4961-4965

[11] ScottonC.J., WilsonJ.L., ScottK., et al. . Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res, 2002, 62(20): 5930-5938

[12] PorcileC., BajettoA., BarbieriF., et al. . Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res, 2005, 08(2): 241-253

[13] ZlotnikA.. Chemokines in neoplastic progression. Semin Cancer Biol, 2004, 14(3): 181-185

[14] ChambersA.F., GroomA.C., MacDonaldI.C.. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer, 2002, 2(8): 563-572

[15] ChristophersonK.W.II, HangocG., MantelC.R., et al. . Modulation of hematopoietic stem cell homing and engraftment by CD26. Science, 2004, 305(5686): 1000-1003

[16] ChungL.W.. Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications. Cancer, 2003, 97(3): 772-778

[17] KryczekI., LangeA., MottramP., et al. . CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res, 2005, 65(2): 465-472

[18] JiangY.P., WuX.H., ShiB., et al. . Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol, 2006, 103(1): 226-233

[19] PeledA., GrabovskyV., HablerL., et al. . The chemokine SDF-1 stimulates integrin-mediated arrest of CD34 (+) cells on vascular endothelium under shear flow. J Clin Invest, 1999, 104(9): 1199-1211

[20] MurakamiT., MakiW., CardonesA.R., et al. . Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res, 2002, 62(24): 7328-7334

[21] BrandS., DambacherJ., BeigelF., et al. . CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res, 2005, 310(1): 117-130

[22] UchidaD., BegumN.M., AlmoftiA., et al. . Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res, 2003, 290(2): 289-302

[23] YuX., HuangY., Collin-OsdobyP., et al. . Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res, 2003, 18(8): 1404-1418